Ling Shan, Ph.D.
Affiliations: | Netherlands Institute for Neuroscience, Amsterdam-Zuidoost, Noord-Holland, Netherlands |
Area:
histamineWebsite:
http://www.lingshancn.weebly.com/Google:
"Ling Shan"Mean distance: 15.87 (cluster 48)
Parents
Sign in to add mentorDick F. Swaab | grad student | 2007-2012 | Netherlands Institute for Neuroscience |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Shan L, Swaab DF. (2025) Histamine 2 receptor: Emerging target for the treatment of attention-deficit/hyperactivity disorder. Cell Reports. Medicine. 6: 102023 |
Zhu HX, Lou WW, Jiang YM, et al. (2025) Histamine Modulation of the Basal Ganglia Circuitry in the Motor Symptoms of Parkinson's Disease. Cns Neuroscience & Therapeutics. 31: e70308 |
Shan L, Linssen S, Harteman Z, et al. (2023) Activated Wake Systems in Narcolepsy Type 1. Annals of Neurology |
Shan L, Balesar R, Swaab DF, et al. (2022) Reduced numbers of corticotropin-releasing hormone neurons in narcolepsy type 1. Annals of Neurology |
Shan L, Swaab DF. (2021) Changes in histaminergic system in neuropsychiatric disorders and the potential treatment consequences. Current Neuropharmacology |
Shan L, Martens GJM, Swaab DF. (2021) Histamine-4 Receptor: Emerging Target for the Treatment of Neurological Diseases. Current Topics in Behavioral Neurosciences |
Shan L, Fronczek R, Lammers GJ, et al. (2021) The tuberomamillary nucleus in neuropsychiatric disorders. Handbook of Clinical Neurology. 180: 389-400 |
Fronczek R, Schinkelshoek M, Shan L, et al. (2021) The orexin/hypocretin system in neuropsychiatric disorders: Relation to signs and symptoms. Handbook of Clinical Neurology. 180: 343-358 |
Fronczek R, Schinkelshoek M, Shan L, et al. (2021) The orexin/hypocretin system in neuropsychiatric disorders: Relation to signs and symptoms. Handbook of Clinical Neurology. 180: 343-358 |
Fang Q, Xicoy H, Shen J, et al. (2020) Histamine-4 receptor antagonist ameliorates Parkinson-like pathology in the striatum. Brain, Behavior, and Immunity |